Recently, the official journal of the European Society of Clinical Microbiology and Infectious Diseases, Clinical Microbiology and Infection (influence factor: 5.394), published “Detection of novel mutations associated with independent and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates”, the latest research results co-conducted by the research team led by Zhang Tianyu from our laboratory, Guangzhou Chest Hospital (PI Tan Yaoju from the research team of Tuberculosis Research Laboratory) and CUHK.